Last reviewed · How we verify
NCT04162405
Tinnitus in Patients With and Without Sensorineural Hearing Loss
trial testing Tinnitus Handicap Inventory Test in Tinnitus, Subjective in 150 participants. Status unknown.
30 June 2020
Quick facts
| Lead sponsor | University Hospital Sestre Milosrdnice |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 1 November 2019 |
| Primary completion | 30 June 2020 |
| Estimated completion | 1 July 2020 |
| Sites | 1 location across Croatia |
Drugs / interventions tested
- Tinnitus Handicap Inventory Test
Conditions studied
- Tinnitus, Subjective — all drugs for Tinnitus, Subjective →
- Hearing Loss — all drugs for Hearing Loss →
- Otorhinolaryngologic Diseases — all drugs for Otorhinolaryngologic Diseases →
Sponsor
University Hospital Sestre Milosrdnice
Who can join
18 and older, any sex, with Tinnitus, Subjective or Hearing Loss. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate hearing characteristics in patients with and without tinnitus using DPOAE and specific tinnitus severity index (TSI) and tinnitus handicap inventory (THI) questionnaires in both groups. Purpose of the research: Demonstrate that the characteristics of tinnitus depend on the presence and magnitude of hearing loss. Research participants: 150 patients coming for further audiological treatment due to tinnitus. Data will be collected from an electronic database that is filled in during diagnostic processing. During the diagnostic processing, TSI and THI questionnaires will be filled in, a tone audiogram (TA) and DPOAE will be performed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04162405
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tinnitus, Subjective
Currently open trials in the same condition.
- NCT07393880 — Bimodal Electrical-Sound Stimulation and Auditory Training for Chronic Tonal Tinnitus · NA · recruiting
- NCT07071480 — Noninvasive Therapy for Tinnitus · NA · recruiting
- NCT07017998 — External Therapy for Tinnitus Management · NA · recruiting
- NCT06880367 — Neuromodulatory Effects of Audio-proprio-phonatory Reinforcement Training on Subjective Tinnitus, Demonstrated by High-d · NA · recruiting
- NCT06782308 — Tinnitus Patient Preferences Survey · recruiting
Other University Hospital Sestre Milosrdnice trials
Trials by the same sponsor.
- NCT07127848 — Investingation on Outcomes After Combining Septoplasty With Additional Procedures. · NA · enrolling by invitation
- NCT06384469 — The Impact of Rhinoplasty Approach and Used Autologous Cartilage Grafts on the Nasal Skin-soft Tissue Envelope Metabolis · not yet recruiting
- NCT05840406 — Effect of a Transversus Abdominis Plane Block on Wound Healing, Stress, and Immune Response After a Cesarean Delivery · NA · completed
- NCT06243536 — The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients · Phase 4 · unknown
- NCT05938985 — Croatian Version of the Ocular Surface Disease Index Questionnaire (OSDI) · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04162405 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Sestre Milosrdnice
- Last refreshed: 20 November 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04162405.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing